Indication
Pulmonary actinomycosis
Pulmonary actinomycosis is a rare, indolent, subacute-to-chronic bacterial infection of the respiratory tract caused by filamentous, anaerobic or microaerophilic, gram-positive bacteria of the genus *Actinomyces*, most commonly *Actinomyces israelii*. Read more about Pulmonary actinomycosis
15 drugs 12 manufacturers
Drugs that treat it
Common Pulmonary actinomycosis therapies.
PENICILLIN G POTASSIUM
PFIZERPEN-G (penicillin G potassium)
PFIZERPEN-G (penicillin G potassium)
PENICILLIN G POTASSIUM
PENICILLIN G POTASSIUM
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPulmonary actinomycosis is a rare, indolent, subacute-to-chronic bacterial infection of the respiratory tract caused by filamentous, anaerobic or microaerophilic, gram-positive bacteria of the genus *Actinomyces*, most commonly *Actinomyces israelii*.
It primarily affects adults—frequently individuals with underlying risk factors such as poor oral hygiene, periodontal disease, alcohol use disorder, or chronic pulmonary disease—following the aspiration of commensal oropharyngeal secretions into the lower airways.
Pathophysiologically, the disease is characterized by slowly progressive, suppurative granulomatous lung parenchymal necrosis, dense fibrosis, abscess formation, and the potential to transgress anatomical tissue planes, sometimes leading to empyema or draining chest wall sinus tracts marked histopathologically by pathognomonic sulfur granules.
Due to its indolent presentation and invasive mass-like infiltrates, it frequently mimics pulmonary tuberculosis or thoracic malignancy.
- nih.gov
Pulmonary actinomycosis is a rare, indolent, subacute-to-chronic bacterial infection of the respiratory tract caused by filamentous, anaerobic or microaerophilic, gram-positive bacteria of the genus *Actinomyces*, most commonly *Actinomyces israelii* Pathophysiologically, the disease is characterized by slowly progressive, suppurative granulomatous lung parenchymal necrosis, dense fibrosis, abscess formation, and the potential to transgress anatomical tissue planes, sometimes leading to empyema ...
- ersnet.org
Pulmonary actinomycosis is a rare, indolent, subacute-to-chronic bacterial infection of the respiratory tract caused by filamentous, anaerobic or microaerophilic, gram-positive bacteria of the genus *Actinomyces*, most commonly *Actinomyces israelii*
- nih.gov
It primarily affects adults—frequently individuals with underlying risk factors such as poor oral hygiene, periodontal disease, alcohol use disorder, or chronic pulmonary disease—following the aspiration of commensal oropharyngeal secretions into the lower airways Due to its indolent presentation and invasive mass-like infiltrates, it frequently mimics pulmonary tuberculosis or thoracic malignancy
- ufhealth.org
It primarily affects adults—frequently individuals with underlying risk factors such as poor oral hygiene, periodontal disease, alcohol use disorder, or chronic pulmonary disease—following the aspiration of commensal oropharyngeal secretions into the lower airways
- nih.gov
Pathophysiologically, the disease is characterized by slowly progressive, suppurative granulomatous lung parenchymal necrosis, dense fibrosis, abscess formation, and the potential to transgress anatomical tissue planes, sometimes leading to empyema or draining chest wall sinus tracts marked histopathologically by pathognomonic sulfur granules
- mdpi.com
Due to its indolent presentation and invasive mass-like infiltrates, it frequently mimics pulmonary tuberculosis or thoracic malignancy
Personalize your experience
Follow Pulmonary actinomycosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.